Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase I
Kadmon Corporation Announces Initial Phase 1b Data For Tesevatinib In Patients With Metastatic Breast Cancer 5/28/2015 10:47:19 AM
Embera NeuroTherapeutics, Inc. Initiates Phase 1 Clinical Trial To Test EMB-001 As A Novel Treatment For Addictions 5/28/2015 9:45:54 AM
TiGenix Release: Safety And Tolerability Of Cx611 Confirmed In Phase I Sepsis Challenge Trial 5/28/2015 8:48:27 AM
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Study Commences For Patients With Two Relapsed/Refractory Blood Cancers 5/28/2015 7:26:28 AM
XBiotech Launching Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus 5/28/2015 6:42:43 AM
PDS Biotechnology Corporation Reports Positive Phase I Clinical Trial Results In Proprietary HPV-Cancer Immunotherapy 5/28/2015 6:14:23 AM
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each 5/20/2015 6:44:18 AM
Anaheim Clinical Trials (ACT) Phase I Clinical Trial Center Selected As A Subcontractor In NIH/National Institute of Allergy And Infectious Diseases (NIAID)’s Therapeutics Against Infectious Disease Initiative 5/27/2015 12:54:44 PM
Cannabis Science Inc. Brings CS-TATI-1 To The FDA With Historic Collaborative Drug Development Deal With IGXBio and Its GenePro, A DNA-Based Immunotherapeutic That Recently Received FDA Approval To Enter Into Human Trials 5/27/2015 10:06:53 AM
G1 Therapeutics Announces Positive Phase Ia Data For CDK4/6 Inhibitor G1T28 5/27/2015 7:18:01 AM
Genelux Corporation Announces Promising Data From Two Phase I Trials Of GL-ONC1 In Head & Neck Cancer And Mesothelioma 5/27/2015 6:57:58 AM
Synageva BioPharma (GEVA) Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Japan 5/27/2015 6:38:05 AM
Stock Soars as bluebird bio (BLUE) Gives Sneak Peek at Promising Sickle Cell Data 5/21/2015 9:15:17 AM
NewLink Genetics (NLNK) To Present Poster On Indoximod, An IDO Pathway Inhibitor, At ASCO Annual Meeting 5/26/2015 11:18:28 AM
R-Tech Ueno: Announcement On Completion Of The Phase I Single-Dose Clinical Trial for the Novel VAP-1 Inhibitor RTU-1096 5/26/2015 11:14:23 AM